Basics ARS Pharmaceuticals, Inc. IPO Date: December 4, 2020 Sector: Healthcare Industry: Biotech Market Cap: $981.57M Activated in VL: True Average Daily Range Avg Daily Range: $0.29 | 2.94% Avg Daily Range (30 D): $0.37 | 4.38% Avg Daily Range (90 D): $0.35 | 3.30% Institutional Daily Volume Avg Daily Volume: 1.01M Avg Daily Volume (30 D): 1.9M Avg Daily Volume (90 D): 2.16M Trade Size Avg Trade Size (Sh.): 90 Avg Trade Size (Sh.) (30 D): 90 Avg Trade Size (Sh.) (90 D): 91 Institutional Trades Total Inst.Trades: 712 Avg Inst. Trade: $1.64M Avg Inst. Trade (30 D): $1.5M Avg Inst. Trade (90 D): $1.76M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.85M Avg Closing Trade (30 D): $1.68M Avg Closing Trade (90 D): $2.23M Avg Closing Volume: 161.24K     News Nov 10, 2025 @ 11:00 AM ARS Pharmaceuticals Reports Third Quarter 2025 Fin... Source: Ars Pharmaceuticals Aug 13, 2025 @ 7:04 PM ARS Pharma Sales Jump 3,040% in Q2 Source: Jesterai Jan 6, 2025 @ 1:00 PM ARS Pharmaceuticals Files for Approval of neffyÂÂ... Source: N/A Dec 13, 2024 @ 9:58 PM ARSファーマシューã... Source: N/A Dec 13, 2024 @ 9:58 PM ARS Pharmaceuticals 宣布在中å›Â... Source: Ars Pharmaceuticals, Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.52 $-.35 Diluted EPS $-.52 $-.35 Revenue $ 32.5M $ $ 7.97M Gross Profit $ $ $ Net Income / Loss $ -51.15M $ $ -33.94M Operating Income / Loss $ -53.19M $ $ -37.18M Cost of Revenue $ $ $ Net Cash Flow $ $ $ -10.95M PE Ratio